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Abstract
The relative role of LH and FSH in regulation of differ-
entiation of Leydig cells was assessed using an ethane
1,2-dimethylsulfonate (EDS)-treated rat model in which
endogenous LH or FSH was neutralized from day 3 to day
22 following EDS treatment. Serum testosterone and the
in vitro response of the purified Leydig cells to human
chorionic gonadotropin (hCG) was monitored. In addition
RNA was isolated from the Leydig cells to monitor
the steady-state mRNA levels by RT-PCR for 17-
hydroxylase, side chain cleavage enzyme, steroidogenic
acute regulatory protein (StAR), LH receptor, estrogen
receptor (ER-) and cyclophilin (internal control). Serum
testosterone was undetected and the isolated Leydig cells
secreted negligible amount of testosterone on stimulation
with hCG in the group of rats that were treated with LH
antiserum following EDS treatment. RT-PCR analysis
revealed the absence of message for cholesterol side chain
cleavage enzyme and 17-hydroxylase although ER-
and LH receptor mRNA could be detected, indicating the
presence of undifferentiated precursor Leydig cells. In
contrast, the effects following deprival of endogenous FSH
were not as drastic as seen following LH neutralization.
Deprival of endogenous FSH in EDS-treated rats led to a
significant decrease in serum testosterone and in vitro
response to hCG by the Leydig cells. Also, there was a
significant decrease in the steady-state mRNA levels of
17-hydroxylase, cholesterol side chain cleavage enzyme,
LH receptor and StAR as assessed by a semiquantitative
RT-PCR. These results establish that while LH is obliga-
tory for the functional differentiation of Leydig cells,
repopulation of precursor Leydig cells is independent of
LH, and also unequivocally establish an important role for
FSH in regulation of Leydig cell function.
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Introduction
Leydig cells are present in the interstitial compartment of
the testes and their main function is to produce testoster-
one, which is essential for spermatogenesis and develop-
ment of secondary sexual characteristics. The testicular
secretion of androgens depends on the Leydig cell number
and also on the activity of Leydig cells (Teerds 1996). This
process involves Leydig cell proliferation and acquisition of
the capacity to produce testosterone, which is associated
with morphological changes, and multiple regulators
govern this process. Luteinizing hormone (LH) is the key
regulator of Leydig cell function and it is indispensable for
functional differentiation and proliferation of Leydig cells
(Benton et al. 1995, Sriraman et al. 2000) although its role
in early development of Leydig cells remain unclear (Ge
et al. 1996, Baker & O’Shaughnessy 2001).
Follicle-stimulating hormone (FSH) has also been
implicated in Leydig cell function through its action on
Sertoli cells (Saez & Lejeune 1996). The precise role of
FSH in male reproduction still remains a debate, although
several lines of evidence suggest that FSH is essential for
initiation of spermatogenesis (Sharpe 1994). The sugges-
tion that Sertoli cells could regulate Leydig cell function is
based on the observation that following induction of
damage to spermatogenesis, hypertrophy of neighbor-
ing Leydig cells was observed (Jegou & Sharpe 1993).
Moreover, using ethane 1,2-dimethylsulfonate (EDS)-
treated rats (EDS is an alkylating agent which specifically
destroys Leydig cells in adult rats) it has been demonstrated
that Leydig cells that are localized at the vicinity of
seminiferous tubules which lack germ cells exhibit faster
regeneration (Jegou & Sharpe 1993). Also, experimental
induction of hypothyroidism led to an increase in Sertoli
cells associated with a parallel increase in Leydig cells,
thereby maintaining the ratio of Leydig cells to Sertoli cells
constant (Cooke et al. 1992). Studies by administering
FSH have also shown a stimulatory role in Leydig cell
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function, but the physiological importance of these find-
ings is a matter of debate, since most of the preparations of
FSH used for the study were contaminated with LH and
hence the observed effects could be attributed to the trace
quantity of LH that was present in the FSH preparation
(Purvis et al. 1979, Moger & Murphy 1982, Lecerf et al.
1993, Saez & Lejeune 1996). However, using recom-
binant FSH preparations, a role for FSH in regulation of
Leydig cell function was demonstrated. Constant infusion
of recombinant human FSH for 7 days to immature
hypophysectomized rats resulted in an increased steroido-
genic responsiveness of Leydig cells (Vihko et al. 1991).
Coculture of Leydig cells with Sertoli cells was also found
to enhance testosterone production, and pretreatment of
these cocultures with FSH further enhanced the capacity
of Leydig cells to produce testosterone (Benahmed et al.
1985). In contrast, using EDS-treated hypophysectomized
or testosterone-implanted rats to suppress LH, Molenaar
et al. (1986) reported that the repopulation of Leydig cells
is FSH-independent and it was speculated that mature
Sertoli cells secreted factors independently of FSH, sug-
gesting that FSH is not required in adult rats. In addition,
it has been reported that FSH- knockout male mice were
fertile with normal serum testosterone levels (Kumar et al.
1997). On the contrary, Dierich et al. (1998) reported that
FSH receptor knockout mice are subfertile and serum
testosterone levels are reduced by 50% when compared
with the wild type and suggested existence of an inter-
cellular communication pathway between Sertoli cells and
Leydig cells. Results of recent studies by Huhtaniemi et al.
(1999) with a hypophysectomized rat model demonstrated
that administration of recombinant FSH increases the
Leydig cell androgen production and LH receptors. Based
on several lines of evidence accumulated using the above
models it has been suggested that if FSH has a role in
Leydig cell function at all, it is essentially only a permissive
role through the Sertoli cell-derived factors. Considering
the controversies that still exist, neither the knockout nor
hypophysectomized model is suitable to study the function
of a particular hormone. In the knockout model there is a
permanent loss of the gene product from the embryonic
stage and it cannot be used to study a stage-specific
function of a hormone. In a hypophysectomized rat model,
there is surgical trauma with loss of all pituitary-derived
hormones and all the pituitary hormones have been
demonstrated to have a role in regulation of testicular
function (Saez & Leujeune 1996).
The objective of the present study is to better under-
stand the relative role of LH and FSH during early Leydig
cell development, using model systems that provide an
opportunity to monitor the role of the hormone by
selective deprival for desired duration. A passive neutrali-
zation approach was employed in an EDS-treated rat
model, where a highly specific antiserum to ovine LH
(oLH) and FSH (oFSH) was used to neutralize endogenous
LH and FSH to assess their relative roles in regulation of
differentiation of Leydig cells during the course of regen-
eration after EDS treatment. The EDS-treated rat model
has been widely used to study the hormonal regulation
of the development of Leydig cells (Kerr et al. 1985,
Molenaar et al. 1986, Morris et al. 1986); within 2–3
weeks after EDS treatment Leydig cell regeneration occurs
and this could be compared with the postnatal develop-
ment of Leydig cells in morphological and functional
characteristics (Teerds 1996).
Materials and Methods
Reagents
EDS was synthesized in the laboratory of Prof. Sri Krishna,
Department of Organic Chemistry, Indian Institute of
Science, Bangalore from ethylene glycol and methansesul-
fonyl chloride as described by Jackson & Jackson (1984).
The purity of the EDS employed was 98% as assessed by
NMR spectroscopy. M-199, Percoll and soya bean trypsin
inhibitor were purchased from Sigma, St Louis, MO,
USA. Collagenase was purchased from Worthington,
Lakewood, NJ, USA. DNAse and Dispase were obtained
from Boehringer Mannheim Ltd, Mannheim, Germany.
[3H]testosterone, Moloney murine leukemia virus reverse
transcriptase and dNTPs were obtained from Amersham
Pharmacia Biotech UK Ltd, Little Chalfont, Bucks, UK.
Primers for PCR and Taq polymerase were obtained from
Bangalore Genei, Bangalore, India. oLH and oFSH were
prepared at the Clinical Research Institute of Montreal,
Quebec, Canada. Rat LH and human chorionic gonado-
tropin (hCG) were kind gifts from Dr A F Parlow,
National Hormone and Pituitary Program, NIDDK,
Bethesda, MD, USA.
Production and characterization of antiserum to oLH
and oFSH
LH antiserum Antiserum to highly purified oLH was
raised in monkeys as described earlier (Sriraman et al.
2000). The antiserum was capable of binding 75% 125I-rat
LH in vitro at a dilution of 1:20 000. The ability of this
antiserum to neutralize endogenous LH in rats was estab-
lished by demonstrating that a single injection of 200 µl
LH antiserum i.p. reduced the serum testosterone by
85–90% in 24 h when compared with the preimmune
serum-treated animals (0·330·04 ng/ml vs 2·87
0·4 ng/ml). Administration of this high-titer LH anti-
serum to adult male rats for 7 days leads to 30%
reduction in testis weight and decreases the serum and
testicular testosterone to undetected levels, demonstrating
the complete neutralization of LH.
FSH antiserum Highly purified oFSH was used for
immunization in adult bonnet monkeys (Selvaraj &
Moudgal 1994). The FSH preparation was affinity purified
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to remove the trace quantities of LH by passing through an
LH antibody affinity column. Before using it for immu-
nization, the purity of FSH was established by checking its
ability to stimulate testosterone production by purified
Leydig cells which respond to added LH (10 ng) by
producing 8- to 10-fold more testosterone over the basal
levels. While addition of 1 µg FSH before purification to
the Leydig cell preparation resulted in an 8-fold increase in
testosterone production, following purification no increase
over basal level was seen even after addition of 2 µg oFSH,
thus establishing the absence of LH contamination.
The ability of antiserum to neutralize endogenous FSH
in rats was established by the observation that when
neonatal rats (10 days old) were administered 100 µl FSH
antiserum i.p. for 7 days, there was a decrease in the
testicular weight by 50% with significant reduction in
seminiferous tubule diameter as assessed by histology of
testes (data not presented). Also, when the steady-state
mRNA levels of androgen-binding protein (ABP) were
assessed by a semiquantitative RT-PCR analysis of the
total RNA from the testis, a 75% reduction in ABP levels
was observed in FSH-deprived animals (data not shown).
ABP is synthesized in Sertoli cells and in the neonatal rat
testis the expression of ABP is regulated by FSH (Tindall
& Means 1976). It is also important to note that in the
monkeys immunized with purified oFSH there was no
detected effect on the nocturnal rise in serum testosterone,
which is an LH-dependent parameter (Mukku et al.
1981). In addition, i.v. administration of 3 ml of this
antiserum to adult male bonnet monkeys also did not
have any effect on the nocturnal surge of serum testoster-
one (control: 31·52·8 ng/ml, FSH antiserum-treated:
322·4 ng/ml). In contrast, administration of LH anti-
serum resulted in complete abolition of the nocturnal
rise in serum testosterone (LH antiserum-treated: 3·45
1 ng/ml).
Table 1 Details of primers employed and expected product size of the PCR amplified cDNA
Sequence of the primer
Product size
(bp)
LH receptor Forward primer
2575-ACT GCT GCG CCT TCA GGA ATT-3Reverse primer
5-CCT AAG GAA GGC ATA GCC CAT-3
Estrogen receptor- Forward primer
3825-CCG GGG AAG CTC CTG TTT G-3Reverse primer
5-AGA GAT GCT CCA TGC CTT TGT TAC-3
17-hydroxylase Forward primer
4155-TCA AAG ACG CCC GGT GCC AA-3Reverse primer
5-ACA GTG ACT TGG CTT CCT GA-3
Cholesterol side chain cleavage enzyme Forward primer
4735-TCA AAG CCA GCA TCA AGG AG-3Reverse primer
5-GCA GCC TGC AAT TCA TAC AG-3
StAR Forward primer
3895-TTG GGC ATA CTC AAC AAC CA-3Reverse primer
5-ATG ACA CCG CTT TGC TCA G-3
IGF-I Forward primer
3275-GCC ACA GCC GGA CCA GAG ACC CTT-3Reverse primer
5-CTA CAT TCT GTA GGT CTT GTT TCC-3
Cyclophilin Forward primer
3805-GTG GCA AGT CCA TCT ACG-3Reverse primer
5-CAG TGA GAG CAG AGA TTA CAG-3
Androgen binding protein Forward primer
3305-ACA ATC TCT GGG CTC GGC TT-3Reverse primer
5-TTG CAG GTC CAC ATC ACA GT-3
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Animals and antiserum treatment
Adult Wistar rats (90 day old) were obtained from the
National Institute of Nutrition, Hyderabad, India. The
animals were housed in an environmentally controlled
facility with 12 h of light and 12 h of darkness and were
allowed free access to food and water. Animals were
administered EDS (75 mg/kg body weight.) in 50%
DMSO i.p. and from 4 days after EDS treatment, the rats
were injected with 500 µl LH antiserum (E+L) or FSH
antiserum (E+F) for 18 days i.p. Control groups were
injected with equal volumes of normal monkey serum
(NMS) (E+N) and vehicle (DMSO)-treated rats also
received normal monkey serum (V+N). Since our own
studies and studies by other groups (Molenaar et al. 1986,
Zhai et al. 1996) have demonstrated that by 3 weeks after
EDS treatment there is a significant recovery in the levels
of serum testosterone and in vitro testosterone production
by Leydig cells, day 23 after EDS treatment was chosen as
the end point of the study. On day 23 rats were killed,
blood was collected for serum testosterone estimation,
testes were weighed and Leydig cells were isolated to assess
the in vitro testosterone production and for RNA isolation.
In order to ensure that the observed effects of LH
or FSH neutralization is under a condition in which the
hormone is neutralized to the maximum that could be
achieved with this approach, the presence of surplus anti-
body in the serum was monitored, which could be used as
an indicator of efficiency of neutralization (Medhamurthy
et al. 1995, Meachem et al. 1998). Conventional RIA
systems cannot be used to measure unneutralized free
hormone in this system since the presence of free antibody
in the serum will interfere with the assay. Serum from E+L
rats showed 20–25% binding to 125I-oLH at 1:50 dilution,
demonstrating the presence of excess antibody which can
neutralize the free LH that can arise in the circulation.
Similar results were observed from the serum obtained
from E+F with 125I-oFSH. We have also observed the
period required to recover partially from the LH deprival
took more than 3 days as seen in the E+L+N group (EDS
and LH antiserum treated and then allowed to recover by
Figure 1 Effect of administration of LH antiserum in EDS-treated
rats from day 4 to day 23 post-EDS treatment on (a) testes weight
and (b) serum testosterone. Values represent meansS.E. from
three separate experiments for six animals in each group. Serum
testosterone in each sample was estimated individually by RIA
after ether extraction. U.D., undetected. ***P<0·001; E+N vs E+L.
V+N, vehicle and NMS treated; E+N, EDS and NMS treated;
E+L, EDS and LH antiserum treated.
Figure 2 Effect of deprivation of endogenous LH on in vitro
testosterone production by Leydig cells isolated from the
EDS-treated rats. Bars corresponding to 1, 3, 5 and 2, 4, 6 indicate
the testosterone values without (basal), and with, hCG
respectively. Values represent meansS.E. from three separate
experiments analyzed in triplicate from six animals in each group.
U.D., undetected; V+N, vehicle and NMS treated; E+N, EDS and
NMS treated; E+L, EDS and LH antiserum treated.
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administration of NMS for 5 days) and importantly even
after 5 days serum testosterone levels could not be restored.
These results essentially demonstrate that the antibody was
always administered in excess to ensure complete neutral-
ization of LH or FSH, and hence the observed effects
are under maximally saturated binding of LH or FSH
antibodies with the circulating hormone.
Isolation of Leydig cells
Leydig cells were isolated according to the procedure of
Klinefelter et al. (1987) and Risbridger & Davies (1994).
Briefly, the decapsulated testes were subjected to colla-
genase digestion in the presence of DNAse. The released
interstitial cells were pooled and subjected to Percoll
density-gradient fractionation. The density gradient was
formed by centrifugation at 20 000 g at 4 C. When
Leydig cells were isolated on day 23 following EDS and
NMS or FSH antiserum treatment, cells which were
positive for 3-hydoxysteroid dehydrogenase (3-HSD)
staining were found in a fraction which had a density
more than 1·068 and were 93% pure. However, in the
EDS- and LH antiserum-treated group while the cells
obtained in the same fraction were homogeneous they did
not stain for 3-HSD. Analysis for the Leydig cells at other
densities in Percoll gradients revealed only erythrocytes at
higher densities (1·084 and above). Damaged cells and
macrophages were seen at lower densities.
Serum testosterone and in vitro testosterone production
All blood samples were processed within 2–3 h after
collection, and serum separated was stored at –20 C until
further use. Testosterone concentrations in the serum
samples were estimated individually after ether extraction
using a sensitive RIA standardized in our laboratory (Rao
& Kotagi 1989). In order to assess the testosterone-
producing capacity of the isolated Leydig cells, 1105
cells were incubated with or without 100 ng hCG (12 000
IU/mg) in 1 ml M-199 medium containing 0·1% BSA at
34 C for 4 h in a shaking water bath, and testosterone
secreted in the medium was determined by a specific RIA
without extraction. In addition to the response of cells to
hCG, the ability of cells to produce testosterone in the
Figure 3 Effect of administration of LH antiserum in EDS-treated rats on the expression of
ER- and LH receptor. Total RNA isolated from purified Leydig cells was reverse transcribed
and cDNA obtained was subjected to PCR for (a) LH receptor (b) ER- and (c) cyclophilin
(internal control). Lane 1, DNA markers, lanes 2–5, PCR-amplified products from V+N,
E+N, E+L, E+L+N groups respectively. Values represent meansS.E. (n=6). V+N, vehicle
and NMS treated; E+N, EDS and NMS treated; E+L, EDS and LH antiserum treated;
E+L+N, EDS and LH antiserum treated and then allowed to recover by administration of
NMS for 5 days.
LH and FSH in Leydig cell differentiation · V SRIRAMAN and others 155
www.endocrinology.org Journal of Endocrinology (2003) 176, 151–161
presence of 22(R)-hydroxycholesterol (20 µM) was also
assessed (Sriraman et al. 2001).
RT-PCR
Total RNA was isolated from Leydig cells (5–8106
cells) using Tri Reagent (Sigma) and intact RNA with an
A260/280 ratio 1·6 and above was used for RT-PCR. One
microgram of total RNA was reverse transcribed by
incubation at 37 C for 1 h with 50 units of reverse
transcriptase in a 20 µl reaction volume containing 200 ng
random hexamers. PCR was carried out with specific
primers within the linear range of amplification to assess
the steady-state mRNA levels for 17-hydroxylase, LH
receptor, cholesterol side chain cleavage enzyme, ster-
oidogenic acute regulatory protein (StAR), estrogen re-
ceptor (ER)- and cyclophilin in a 50 µl reaction mixture
with 2·5 µl RT mixture containing the cDNA. The details
of the primers used and size of the PCR-amplified
products are listed in Table 1. Each PCR product was
sequenced for its authenticity (data not included). To
visualize, the products were analyzed on 1·5% agarose gel
with ethidium bromide in Tris–borate/EDTA buffer. The
differences in intensity of the products following electro-
phoretic analysis were analyzed using an EDAS 120 Kodak
Gel Documentation system.
Statistical analysis of data
The data were analyzed by Kruskal–Wallis ANOVA
followed Neuman–Keuls test to identify significant differ-
ences in the group employing Graphpad software (San
Diego, CA, USA), and a P value less than 0·05 was
considered to be statistically significant. The data pre-
sented in the figures are representative of at least three
independent experiments.
Results
Effect of administration of LH antiserum in EDS-treated rats
Testes weight and serum testosterone To assess the
role of LH in regulation of development of Leydig cells,
EDS-treated adult rats were deprived of endogenous LH
by administering LH antiserum from day 4 to day 22
post-EDS treatment. On day 23, when analyzed for their
testicular weight, there was significant decrease in the
E+L group (compare E+L and E+N) (Fig. 1a) and serum
testosterone was not detected in the E+L group (Fig. 1b).
These results demonstrate that endogenous neutralization
of LH in EDS-treated rats led to a decrease in serum
testosterone to undetected levels and this was associated
with drastic decrease in the testicular weight.
Figure 4 Effect of administration of LH antiserum in EDS-treated rats on the expression of
17-hydroxylase and cholesterol side chain cleavage enzyme. Total RNA isolated from
purified Leydig cells was reverse transcribed and cDNA obtained was subjected to PCR for
(a) 17-hydroxylase, (b) cholesterol side chain cleavage enzyme (SCC) and (c) cyclophilin
(internal control). Lane 1, DNA markers, lanes 2–5, PCR-amplified products from V+N,
E+N, E+L, E+L+N groups respectively. V+N, vehicle and NMS treated; E+N, EDS and NMS
treated; E+L, EDS and LH antiserum treated; E+L+N, EDS and LH antiserum treated and
then allowed to recover by administration of NMS for 5 days. Values represent meansS.E.
(n=6). U.D., undetected.
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In vitro testosterone production Leydig cells were
isolated from V+N, E+N and E+L groups and analyzed for
their in vitro testosterone-producing capacity at basal and
hCG-stimulated conditions. Leydig cells from V+N- and
E+N-treated groups produced 10-fold more testosterone
following addition of hCG, compared with their basal
production (Fig. 2). On the contrary, upon stimulation of
Leydig cells isolated from the E+L group with hCG,
testosterone could not be detected in the medium. These
results demonstrate that endogenous neutralization of
LH in EDS-treated rats results in impaired response to
Figure 5 Effect of administration of FSH antiserum in EDS treated
rats from day 4 to day 23 post-EDS treatment on (a) testis weight
and (b) serum testosterone. Values represent meansS.E. from
three separate experiments for six animals in each group. Serum
testosterone in each sample was estimated individually by RIA
after ether extraction. ***P<0·001, **P<0·01; E+N vs E+F. V+N,
vehicle and NMS treated; E+N, EDS and NMS treated; E+F, EDS
and FSH antiserum treated.
Figure 6 Effect of deprival of FSH in EDS treated rats on (a) basal,
(b) hCG-stimulated and (c) 22(R)-hydroxycholesterol-saturated
in vitro testosterone production. Values represent meansS.E.
from three separate experiments cultured in triplicate with six
animals in each group. ***P<0·001, **P<0·01; E+N vs E+F. V+N,
vehicle and NMS treated; E+N, EDS and NMS treated; E+F, EDS
and FSH antiserum treated.
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hCG-stimulated testosterone production in vitro and estab-
lish the absolute requirement for LH in testosterone
production.
RT-PCR analysis for LH-receptor, ER-, 17-
hydroxylase, and cholesterol side chain cleavage en-
zyme mRNA It has been well documented that LH
receptor and ER- are localized in the Leydig cells in the
interstitial compartment of the testis and their presence can
be used as marker for establishing the identity of Leydig
cells. Moreover, 17-hydroxylase and cholesterol side
chain cleavage enzyme are the key steroidogenic enzymes
involved in the testosterone biosynthetic pathway and
hence assessing their steady-state mRNA levels would
reflect the steroidogenic capacity of the Leydig cells.
When the RNA isolated from Leydig cells purified from
EDS-treated rats deprived of endogenous LH was analyzed
for LH receptor (position 846–1101 of rat LH/hCG
receptor DNA sequence, which is necessary for binding
and signal transduction (Reiter et al. 1995)) and ER- by
RT-PCR (35 cycles), both the messages could be detected
(Fig. 3). Similarly, mRNAs for LH receptor and ER-
 could be detected in the V+N and E+N groups.
However, when mRNA levels of 17-hydroxylase and
cholesterol side chain cleavage enzyme were monitored,
no messages could be detected in the EDS- and LH
antiserum-treated groups, despite amplification for 40
cycles (Fig. 4), although the message for 17-hydroxylase
and cholesterol side chain cleavage enzyme could be
detected in V+N and E+N groups. Upon termination of
LH antiserum treatment to recover from LH deprival from
day 22 for 5 days (by administration of NMS; E+L+N),
the messages for 17-hydroxylase and cholesterol side
chain cleavage enzyme could be detected (Fig. 4). These
results demonstrate that precursor Leydig cells can repopu-
late in testes even in the absence of LH but require LH for
their functional differentiation.
Effect of administration of FSH antiserum in EDS-treated rats
Testes weight and serum testosterone Following
administration of FSH antiserum in EDS-treated rats from
Figure 7 Semiquantitative RT-PCR analyses in RNA obtained from
purified Leydig cells following deprival of endogenous FSH in
EDS-treated adult rats. In the left panels, total RNA isolated from
the isolated Leydig cells was reverse transcribed and cDNA
obtained was subjected to a semiquantitative PCR in the linear
range of amplification for (a) StAR, (b) cholesterol side chain
cleavage enzyme, (c) 17-hydroxylase, (d) LH receptor, (e) IGF-I
and (f) cyclophilin (internal control). Lanes 1–3 correspond to
PCR-amplified products from V+N, E+N and E+F treated groups
respectively. In the right panels, the intensity of the signals was
quantified by densitometry and normalized to that of cyclophilin.
The data provided are meansS.E. from three separate
experiments with six animals in each group. ***P<0·001,
**P<0·01; E+N vs E+F. V+N, vehicle and NMS treated; E+N,
EDS and NMS treated; E+F, EDS and FSH antiserum treated.
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day 4 to day 22 post-EDS treatment there was a significant
decrease in testis weight and serum testosterone (Fig. 5a
and b). The observed reduction in serum testosterone was
not as drastic as seen in the case of the LH-deprived group.
In vitro testosterone production When Leydig cells
isolated from EDS- and FSH antiserum-treated animals
(E+F) were assessed for their in vitro testosterone-
producing capacity, there was no change in their
basal testosterone production but interestingly there
was a significant decrease in hCG-stimulated and
22(R)-hydroxycholesterol-saturated testosterone produc-
tion when compared with the E+N group (Fig. 6). These
results establish that endogenous neutralization of FSH
results in a significant decrease in steroidogenic capacity of
Leydig cells, although the effects are not as drastic as seen
in the case of LH-deprived animals.
RT-PCR analysis of 17-hydroxylase, cholesterol
side chain cleavage enzyme, StAR, LH receptor and
insulin-like growth factor-I (IGF-I) mRNA In order
to assess the effect of neutralization of endogenous FSH
in EDS-treated rats on the steroidogenic machinery, the
steady-state mRNA levels of 17-hydroxylase, cholesterol
side chain cleavage enzyme, StAR, LH receptor and
IGF-I were assessed by a semiquantitative RT-PCR
within the linear range of amplification employing cyclo-
philin as internal control (30 cycles for all the parameters
except for cyclophilin, which was amplified for 26 cycles).
The linear range and the number of cycles were deter-
mined by measuring the amplification of the cDNA at
different cycles as described previously (Sriraman et al.
2000). Analysis revealed a significant decrease in both
cholesterol side chain cleavage enzyme and 17-
hydroxylase (Fig. 7). There was also a decrease in steady-
state mRNA of StAR (Fig. 7) but the extent of decrease
was not as much as that seen in the case of cholesterol side
chain cleavage enzyme and 17-hydroxylase. In addition,
assessment of steady-mRNA levels of LH receptor and
IGF-I (Fig. 7) also revealed a significant decrease. These
results demonstrate that endogenous neutralization of FSH
in EDS-treated rats resulted in reduction in expression of
key molecules involved in steroidogenesis and the factors
that regulate this process.
Discussion
Earlier studies have established a role for LH in Leydig cell
regeneration after EDS treatment, but the precise role of
LH in the developmental events associated with regener-
ation and the requirement of FSH in the differentiation
process have not been well studied. Towards this a passive
neutralization approach was employed in EDS-treated rats
and 23 days after EDS treatment was chosen as an end
point of the study since steroidogenic capacity of Leydig
cells could be monitored easily.
The results obtained in the present study confirm that
there is an LH-independent stage in the development of
Leydig cells and this is contrary to the absolute require-
ment of LH for functional differentiation. Administration
of LH antiserum to EDS-treated rats resulted in reduction
of serum testosterone and in vitro testosterone-producing
capability of purified Leydig cells to not-detected levels.
Analysis for steady-state mRNA levels of cholesterol side
chain cleavage enzyme and 17-hydroxylase by RT-PCR
in isolated Leydig cells after EDS and LH antiserum
treatment revealed its total absence. In contrast, the
message for LH receptor and ER- could be detected and
it is generally agreed that LH receptor (Benton et al. 1995,
Tena-Sempere et al. 1997) and ER- (Nozuk et al. 1981,
Lin et al. 1982, Zhai et al. 1996) are localized in Leydig
cells of the interstitial compartment of the testis. Earlier
studies indicate that the Leydig cell capacity for testoster-
one synthesis correlates with the levels of cholesterol side
chain cleavage enzyme and 17-hydroxylase; it has been
well documented that LH can influence its expression
(Payne 1990, Lin 1996, Payne & Shaughnessy 1996).
These results establish that while precursor Leydig cells
repopulated in the testes in an LH-independent manner,
there is an absolute requirement of LH for their functional
differentiation. It is interesting to note here that Leydig
cell precursors expressed LH receptor in the absence of
LH, which is essential for subsequent maturation steps
including the onset of steroidogenesis under the influence
of LH. These results confirm and extend the previous
reports on the evidence for the presence of LH receptor
in Leydig cell precursors (Moore & Morris 1993,
Tena-Sempere et al. 1997), which remained controversial.
Careful analysis of the results of the present study and our
earlier studies (Sriraman et al. 2000) with other reports
(Teerds 1989a,b) reveal two waves of Leydig cell pro-
liferation, one which occurs independently of LH which
subsequently forms progenitor Leydig cells, and the next
wave of proliferation occurs under the control of LH and
other factors that determine the final Leydig cell number
in the testes. The observed requirement of LH in adult
Leydig cell development is different from development
of fetal Leydig cells, which proliferate and differentiate
independently of LH (Baker & O’Shaughnessy 2001).
Endogenous neutralization of FSH led to a reduction in
steroidogenic capacity of Leydig cells with a decrease in
the steady-state mRNA levels of 17-hydroxylase and
cholesterol side chain cleavage enzyme. The observed
reduction in steroidogenesis was not as drastic as that of LH
deprival. There was also a significant reduction in steady-
state mRNA levels of StAR, which transports cholesterol
from the cytosol to the mitochondria, and it is a key
regulatory step in acute regulation of steroidogenesis
(Stocco 1996). Moreover, a reduction in the steady-state
mRNA levels of LH receptor and IGF-I was observed
following FSH neutralization. It has been well docu-
mented that IGF-I secreted by the Leydig cells can act in
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an autocrine fashion to induce LH receptor and enhance
proliferation and steroidogenesis (Lin 1996), and that FSH
causes the prepubertal rise in IGF-I in the testis (Closset
et al. 1989). Thus it is possible that neutralization of FSH
resulted in a decrease in the stimulatory factors derived
from Sertoli cells which are capable of enhancing the
message for LH receptor and IGF-I, which in turn
stimulates steroidogenesis in the Leydig cells. It is neces-
sary to emphasize here that the observed effects are only
due to FSH neutralization and more importantly the
antiserum employed had no contaminating LH antibodies,
which was established by the lack of any effect on the
nocturnal rise in serum testosterone when administered to
adult bonnet monkeys, which is sensitive to LH deprival
(Mukku et al. 1981). It is important to note that the LH
levels are very high following EDS treatment (peaks
by 3 weeks about 6-fold over the normal levels and
starts declining thereafter to reach normal levels by 6
weeks) due to lack of feedback inhibition by testosterone
(Tena-Sempere et al. 1997) and interestingly the decrease
in Leydig cell function observed following FSH depri-
vation is when the levels of LH are high due to reduction
in testosterone levels following EDS treatment. Previous
studies employing EDS-treated rats have clearly shown
that negative feedback of testicular factors on LH secretion
is mediated completely through changes in gonadotropin-
releasing hormone action via testosterone (Tena-Sempere
et al. 1995) and hence the observed effects are not due to
alterations in LH levels following FSH antiserum treat-
ment. These results clearly establish that FSH has an
important role in regulation of Leydig cell function
indirectly during regeneration following EDS treatment,
and this is in clear contradiction to the results obtained by
Moolenar et al. (1986).
It is important to note that the earlier studies employed
EDS-treated models to investigate the role of LH and FSH
by hypophysectomy or administering steroids, but all these
approaches suffer from one or more disadvantages. By
administering steroids one cannot control the extent of
inhibition of LH and the direct effect due to steroids. The
passive neutralization approach has the unique advantage
of depriving a specific hormone for a desired period of
time. The usefulness of specific antibodies to investigate
the role of LH and FSH in rats and monkeys has been well
established earlier (Rao et al. 1970, Moudgal et al. 1974,
Selvaraj & Moudgal 1994). Earlier studies have also
demonstrated that immunoneutralization leads to com-
plete neutralization of the endogenous hormone, bringing
the free hormone levels below the level of detection and
the administered excess antibody stays in the circulation
(Medhamurthy et al. 1995, Meachem et al. 1998, 1999).
Considering the fact that levels of LH and FSH were high
after EDS treatment, the antiserum was always adminis-
tered in excess, which was confirmed by the detection of
free antibodies in serum. Moreover, all the studies were
carried out with purified Leydig cells from EDS-treated
rats by a method validated by Klinefelter et al. (1987) and
Risbridger & Davies (1994), in contrast to the other
studies which were carried out with interstitial cells or
testicular slices. To conclude, the present study has pro-
vided conclusive evidence for a stage in Leydig cell
development which is independent of LH and the
absolute need for LH in functional differentiation. Also,
the importance of FSH in regulation of Leydig cell
function through its action on the Sertoli cells has been
demonstrated.
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